641 related articles for article (PubMed ID: 8913360)
1. Direct inhibition of 5-hydroxytryptamine3 receptors by antagonists of L-type Ca2+ channels.
Hargreaves AC; Gunthorpe MJ; Taylor CW; Lummis SC
Mol Pharmacol; 1996 Nov; 50(5):1284-94. PubMed ID: 8913360
[TBL] [Abstract][Full Text] [Related]
2. Ca2+ permeability of cloned and native 5-hydroxytryptamine type 3 receptors.
Hargreaves AC; Lummis SC; Taylor CW
Mol Pharmacol; 1994 Dec; 46(6):1120-8. PubMed ID: 7808432
[TBL] [Abstract][Full Text] [Related]
3. Palonosetron exhibits unique molecular interactions with the 5-HT3 receptor.
Rojas C; Stathis M; Thomas AG; Massuda EB; Alt J; Zhang J; Rubenstein E; Sebastiani S; Cantoreggi S; Snyder SH; Slusher B
Anesth Analg; 2008 Aug; 107(2):469-78. PubMed ID: 18633025
[TBL] [Abstract][Full Text] [Related]
4. Voltage-dependent calcium channels in the rat retina: involvement in NMDA-stimulated influx of calcium.
Melena J; Osborne NN
Exp Eye Res; 2001 Apr; 72(4):393-401. PubMed ID: 11273667
[TBL] [Abstract][Full Text] [Related]
5. Modulation of voltage-dependent calcium currents by serotonin in acutely isolated rat amygdala neurons.
Lin CH; Huang YC; Tsai JJ; Gean PW
Synapse; 2001 Sep; 41(4):351-9. PubMed ID: 11494406
[TBL] [Abstract][Full Text] [Related]
6. Effects of Ca++ on [3H]diltiazem binding and its allosteric interaction with dihydropyridine calcium channel binding sites in the rat cortex.
Schoemaker H; Langer SZ
J Pharmacol Exp Ther; 1989 Feb; 248(2):710-5. PubMed ID: 2537412
[TBL] [Abstract][Full Text] [Related]
7. High calcium permeability of serotonin 5-HT3 receptors on presynaptic nerve terminals from rat striatum.
Rondé P; Nichols RA
J Neurochem; 1998 Mar; 70(3):1094-103. PubMed ID: 9489730
[TBL] [Abstract][Full Text] [Related]
8. Characterization of interaction of 3,4,5-trimethoxybenzoic acid 8-(diethylamino)octyl ester with Torpedo californica nicotinic acetylcholine receptor and 5-hydroxytryptamine3 receptor.
Sun H; McCardy EA; Machu TK; Blanton MP
J Pharmacol Exp Ther; 1999 Jul; 290(1):129-35. PubMed ID: 10381768
[TBL] [Abstract][Full Text] [Related]
9. Characterization of [3H]meta-chlorophenylbiguanide binding to 5-HT3 receptors in N1E-115 neuroblastoma cells.
Lummis SC; Sepúlveda MI; Kilpatrick GJ; Baker J
Eur J Pharmacol; 1993 Oct; 243(1):7-11. PubMed ID: 8253126
[TBL] [Abstract][Full Text] [Related]
10. Identification of serotonin 5-HT3 recognition sites in membranes of N1E-115 neuroblastoma cells by radioligand binding.
Hoyer D; Neijt HC
Mol Pharmacol; 1988 Mar; 33(3):303-9. PubMed ID: 3352595
[TBL] [Abstract][Full Text] [Related]
11. Competitive and cooperative effects of Bay K8644 on the L-type calcium channel current inhibition by calcium channel antagonists.
Zahradníková A; Minarovic I; Zahradník I
J Pharmacol Exp Ther; 2007 Aug; 322(2):638-45. PubMed ID: 17475903
[TBL] [Abstract][Full Text] [Related]
12. High-affinity binding of DTZ323, a novel derivative of diltiazem, to rabbit skeletal muscle L-type Ca++ channels.
Hagiwara M; Adachi-Akahane S; Nagao T
J Pharmacol Exp Ther; 1997 Apr; 281(1):173-9. PubMed ID: 9103495
[TBL] [Abstract][Full Text] [Related]
13. Direct activation by dopamine of recombinant human 5-HT1A receptors: comparison with human 5-HT2C and 5-HT3 receptors.
Oz M; Zhang L; Rotondo A; Sun H; Morales M
Synapse; 2003 Dec; 50(4):303-13. PubMed ID: 14556235
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological, radioligand binding, and electrophysiological characteristics of FPL 64176, a novel nondihydropyridine Ca2+ channel activator, in cardiac and vascular preparations.
Zheng W; Rampe D; Triggle DJ
Mol Pharmacol; 1991 Nov; 40(5):734-41. PubMed ID: 1719369
[TBL] [Abstract][Full Text] [Related]
15. Calcium influx through presynaptic 5-HT3 receptors facilitates GABA release in the hippocampus: in vitro slice and synaptosome studies.
Turner TJ; Mokler DJ; Luebke JI
Neuroscience; 2004; 129(3):703-18. PubMed ID: 15541891
[TBL] [Abstract][Full Text] [Related]
16. Biguanide derivatives: agonist pharmacology at 5-hydroxytryptamine type 3 receptors in vitro.
Morain P; Abraham C; Portevin B; De Nanteuil G
Mol Pharmacol; 1994 Oct; 46(4):732-42. PubMed ID: 7969053
[TBL] [Abstract][Full Text] [Related]
17. Allosteric modulation of 5-HT3 serotonin receptors.
Maksay G; Bíró T; Bugovics G
Eur J Pharmacol; 2005 May; 514(1):17-24. PubMed ID: 15878320
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of calcium channel inhibition by phenytoin: comparison with classical calcium channel antagonists.
Messing RO; Carpenter CL; Greenberg DA
J Pharmacol Exp Ther; 1985 Nov; 235(2):407-11. PubMed ID: 2414431
[TBL] [Abstract][Full Text] [Related]
19. Serotonin induces the increase in intracellular Ca2+ that enhances neurite outgrowth in PC12 cells via activation of 5-HT3 receptors and voltage-gated calcium channels.
Homma K; Kitamura Y; Ogawa H; Oka K
J Neurosci Res; 2006 Aug; 84(2):316-25. PubMed ID: 16688720
[TBL] [Abstract][Full Text] [Related]
20. Characterization of YM060, a potent and selective 5-hydroxytryptamine3 receptor antagonist, in rabbit nodose ganglion and N1E-115 neuroblastoma cells.
Ito H; Hidaka K; Miyata K; Kamato T; Nishida A; Honda K
J Pharmacol Exp Ther; 1992 Dec; 263(3):1127-32. PubMed ID: 1469624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]